CANDEL THERAPEUTICS INC (CADL:NASDAQ)
$8.3 0.21 (2.5958%)
Analysed CANDEL THERAPEUTICS INC (CADL:NASDAQ) News Sources
Candel Therapeutics reports extended survival in Phase 2a lung cancer trial of CAN-2409
17-03-2026
proactiveinvestors.com
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
29-04-2026
yahoo.com
Candel Therapeutics teams up with EVERSANA to prep for prostate cancer drug launch
29-04-2026
proactiveinvestors.com
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-05-2026
yahoo.com
Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
04-05-2026
yahoo.com
Candel Therapeutics to Present at Upcoming Investor Conferences
13-05-2026
yahoo.com
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
14-05-2026
yahoo.com
Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting
15-05-2026
yahoo.com
Wall Street Analysts Believe Candel Therapeutics (CADL) Could Rally 148.48%: Here's is How to Trade
19-05-2026
yahoo.com
Candel Therapeutics Eyes Year-End BLA After Strong Prostate Cancer Data
20-05-2026
marketbeat.com
What is the current price of CANDEL THERAPEUTICS INC (CADL:NASDAQ)?
The current price of CANDEL THERAPEUTICS INC (CADL:NASDAQ) is $8.3.
CANDEL THERAPEUTICS INC (CADL:NASDAQ) absolute price change since previous trading day?
The absolute price change of CANDEL THERAPEUTICS INC (CADL:NASDAQ) since the previous trading day is $0.21.
CANDEL THERAPEUTICS INC (CADL:NASDAQ) percentage price change since previous trading day?
The percentage price change of CANDEL THERAPEUTICS INC (CADL:NASDAQ) since the previous trading day is 2.5958%.
What is the most recent average sentiment score for CANDEL THERAPEUTICS INC (CADL:NASDAQ)?
The most recent average sentiment score for CANDEL THERAPEUTICS INC (CADL:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for CANDEL THERAPEUTICS INC (CADL:NASDAQ)?
The most recent sentiment for CANDEL THERAPEUTICS INC (CADL:NASDAQ) is .
SEC-8K** Filing Available For CANDEL THERAPEUTICS INC (CADL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.